Navigation

News

Your contact person

Manager PR & Communications Jan Phillip Denkers

Filter reset
Hans Kuhn hands over responsibilities to his successors Mariela Aranda (left) and Julianna Shibao (right).
Hans Kuhn hands over responsibilities to his successors Mariela Aranda (left) and Julianna Shibao (right). (Picture: altona Diagnostics)

New management at altona Diagnostics in Argentina and Brazil

After more than six years at the helm of the Argentine and Brazilian subsidiaries of altona Diagnostics based in Buenos ...

Read more …
To illustrate the type of environments in which gold nanoparticles can be used, the nanoparticles approach densely packed regions of proteins. (Image: Ferdinand Otto, UHH)
To illustrate the type of environments in which gold nanoparticles can be used, the nanoparticles approach densely packed regions of proteins. (Image: Ferdinand Otto, UHH)

"Stealth Effect"

An experiment led by a team of DESY and Universität Hamburg scientists has discovered that gold nanoparticles can move through liquid ...

Read more …
Evotec has started the search for a permanent solution for the position of CEO.

Evotec announces CEO transition

Evotec SE announced that after close to 15 years of successful service, CEO Dr Werner Lanthaler has informed the company, that he will not continue ...

Read more …
Johanna Hakanpää, scientist in charge of beamline P11, in conversation with Serghei Glinca, founder and CEO of CrystalsFirst. ( Photo: DESY)
Johanna Hakanpää, scientist in charge of beamline P11, in conversation with Serghei Glinca, founder and CEO of CrystalsFirst. ( Photo: DESY)

Cooperation for faster drug discovery

The mutual project “LigandML” receives funding by the IFB Hamburg aiming to leverage experimental capabilities for better data quality paired ...

Read more …
Onco AI-Med meeting at Indivumed: Dr. David Kerr, Nils Schumacher, Prof. Gerry Melino, Nina Gabelia, Dr. John Marshall, Dr. Takayuki Yoshino, Prof. Hartmut Juhl, Dr. Sun Young Rha, Dr. Jesus Garcia-Foncillas, Dr. Carlos Sampaio and Dr. David Gallagher (fr
Onco AI-Med meeting at Indivumed: Dr. David Kerr, Nils Schumacher, Prof. Gerry Melino, Nina Gabelia, Dr. John Marshall, Dr. Takayuki Yoshino, Prof. Hartmut Juhl, Dr. Sun Young Rha, Dr. Jesus Garcia-Foncillas, Dr. Carlos Sampaio and Dr. David Gallagher (from left to right) (Picture: Indivumed)

Indivumed Hosts Onco AI-Med Annual Board Meeting in Hamburg

Indivumed Therapeutics (“Indivumed”) welcomed members of the Oncology Alliance For Individualized Medicine (“Onco AI-Med”) to its global headquarters in Hamburg, ...

Read more …
LSN Managing Director Dr. Jürgen Walkenhorst and State Councillor Andreas Rieckhof visit Managing Director Dr. Frank Horling at BioAgilytix European Headquarters in Hamburg (from left to right) (Image: BioAgilytix)
LSN Managing Director Dr. Jürgen Walkenhorst and State Councillor Andreas Rieckhof visit Managing Director Dr. Frank Horling at BioAgilytix European Headquarters in Hamburg (from left to right) (Image: BioAgilytix)

#LifeScienceTour visits BioAgilytix

Andreas Rieckhof, State Councilor for Economic Affairs, LSN Managing Director Dr. Jürgen Walkenhorst and Juliane Worm, LSN Director Innovation & Technologies, visited the European headquarters ...

Read more …
Bastian Rouven Brückner, Head of Operations, Merck Group/AmpTec GmbH, Peter Scheinert, Founder & CEO, AmpTec GmbH, Prof. Simone Spuler, Head of the Myology Lab at the Experimental and Clinical Research Center (ECRC), Dr. Matthias Jöhnck, Senior Director m
Bastian Rouven Brückner, Head of Operations, Merck Group/AmpTec GmbH, Peter Scheinert, Founder & CEO, AmpTec GmbH, Prof. Simone Spuler, Head of the Myology Lab at the Experimental and Clinical Research Center (ECRC), Dr. Matthias Jöhnck, Senior Director mRNA Value Chain, Synthesis & ADC, Merck Life Science Services and MD AmpTec GmbH and Tanja Stadie, Head Of Quality, Merck Group/AmpTec GmbH at the official opening of the new mRNA production facility in Hamburg. (from left - Image: Merck KGaA)

Merck/AmpTec: New mRNA manufacturing site opened in Hamburg

Merck, a leading science and technology company, today became the first CTDMO (contract testing, development and manufacturing organization) to offer integrated services for all critical ...

Read more …
Cellbox Ground 2.0 ushers in a new era of cell shipping: Live Cell Shipping.
Cellbox Ground 2.0 ushers in a new era of cell shipping: Live Cell Shipping. (Image: Cellbox Solutions)

Cellbox Solutions Awarded €2.5 Million Grant

Cellbox Solutions GmbH, a leading provider of warm chain logistics solutions for the research, development and shipment of cell-based therapies and cellular diagnostics, today announced ...

Read more …
Tiprelestat will be administered to patients hospitalized due to COVID-19 with the goal of reducing the duration of severe COVID-19.
Tiprelestat will be administered to patients hospitalized due to COVID-19 with the goal of reducing the duration of severe COVID-19. (Photo Credit: Alissa Eckert, MSMI; Dan Higgins, MAMS)

tiakis: Treatment of COVID-19

tiakis Biotech AG announced today that a first patient has been dosed in the COMCOVID trial, a Phase Ib/II trial evaluating the Company’s key investigational ...

Read more …
From left to right: a pollen grain collected at DESY, a diatom, and a cyanobacterium, all imaged using Compton X-ray Scattering Microscopy at PETRA III.
From left to right: a pollen grain collected at DESY, a diatom, and a cyanobacterium, all imaged using Compton X-ray Scattering Microscopy at PETRA III. (Image: ©DESY/CFEL)

Biological specimens imaged with X-rays without damage

A pollen grain showing the nanofoam within or a diatom with the individual geometric structures inside clearly visible: Using high-energy X-rays from the PETRA III ...

Read more …
Hamburg's Senator for Economics and Innovation, Dr. Melanie Leonhard, met Dr. Werner Lanthaler, Evotec CEO (left), and Dirk Winkler, SVP Hit Identification, Global Drug Discovery Services at Evotec (right), during her visit to the Manfred Eigen campus.
Hamburg's Senator for Economics and Innovation, Dr. Melanie Leonhard, met Dr. Werner Lanthaler, Evotec CEO (left), and Dirk Winkler, SVP Hit Identification, Global Drug Discovery Services at Evotec (right), during her visit to the Manfred Eigen campus. ( Picture: © Nico Michaelsen, Evotec SE)

Senator Dr. Melanie Leonhard visits Evotec

Evotec SE announced that new high-throughput screening (“HTS”) facilities at the Company’s headquarters in Hamburg, as well as additional equipment for investigating ...

Read more …
tiakis focuses on the discovery and development of therapeutic solutions based on its innovative biopharmaceutical Tiprelestat for life threatening surgeries and life-threatening diseases such as PAH and COVID-19.
tiakis focuses on the discovery and development of therapeutic solutions based on its innovative biopharmaceutical Tiprelestat for life threatening surgeries and life-threatening diseases such as PAH and COVID-19. (Image: ©stock.adobe.com/Gorodenkoff)

tiakis Biotech AG and Northway Biotech collaborate

tiakis Biotech AG (tiakis), in collaboration with its CDMO partner Northway Biotech, is pleased to announce the successful ...

Read more …
Job board